Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/63564
Full metadata record
DC FieldValueLanguage
dc.contributor.authorViboonjuntra, Pongtepen
dc.date.issued2006en
dc.identifier.urihttp://hdl.handle.net/2440/63564-
dc.description.abstractThe aim of this study was to test whether GM-CSF could modulate the response of chronic myeloid leukemia progenitors to imatinib. In addition it was aimed to examine CML cell production of GM-CSF. Findings suggest that non-CD34+ cells may be a source of GM-CSF.en
dc.subjectgranulocyte-macrophage colony-stimulating factor; imatinib; chronic myeloid leukemia gene therapyen
dc.titleGM-CSF protection of CML CD34+ cells from the inhibitory effect of imatinib.en
dc.typeThesisen
dc.contributor.schoolSchool of Medicine, Division of Haematologyen
dc.provenanceThis electronic version is made publicly available by the University of Adelaide in accordance with its open access policy for student theses. Copyright in this thesis remains with the author. This thesis may incorporate third party material which has been used by the author pursuant to Fair Dealing exception. If you are the author of this thesis and do not wish it to be made publicly available or If you are the owner of any included third party copyright material you wish to be removed from this electronic version, please complete the take down form located at: http://www.adelaide.edu.au/legalsen
dc.description.dissertationThesis (Ph.D.) - University of Adelaide, School of Medicine, 2006en
Appears in Collections:Research Theses

Files in This Item:
File Description SizeFormat 
01front.pdf70.23 kBAdobe PDFView/Open
02whole.pdf16.9 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.